Your session is about to expire
← Back to Search
Diagnostic Test
TruGraf for Immunosuppression
N/A
Waitlist Available
Led By Ram Peddi
Research Sponsored by Transplant Genomics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to month 12
Awards & highlights
Study Summary
This trial is testing whether reducing immunosuppression medication helps kidney transplant patients.
Eligible Conditions
- Kidney Transplant Rejection
- Immunosuppression
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to month 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to month 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Banff pathology
Cost of patient care
Physicians decided to reduce immunosuppression
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TruGraf - Group 1:Experimental Treatment1 Intervention
Patients randomized to Group 1 will receive serial TruGraf testing at months 3, 4, 5, 6, 7, 8, 9, and 12. Results will be available in real-time and used by the physician to guide management of immunosuppression.
Group II: CPMC Standard of Care - Group 2:Active Control1 Intervention
Patients randomized to Group 2 or CPMC Standard of Care Group patients will have current standard of care laboratory assessments.
Find a Location
Who is running the clinical trial?
Transplant Genomics, Inc.Lead Sponsor
13 Previous Clinical Trials
3,925 Total Patients Enrolled
1 Trials studying Immunosuppression
17 Patients Enrolled for Immunosuppression
California Pacific Medical CenterOTHER
12 Previous Clinical Trials
8,095 Total Patients Enrolled
Ram PeddiPrincipal InvestigatorCalifornia Pacific Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have received a specific type of medication called Thymoglobulin and have successfully stopped taking corticosteroids.You are currently taking corticosteroids (steroid medication) for a medical condition.You need to have a kidney transplant only. If you need a transplant for another organ as well, you cannot participate.
Research Study Groups:
This trial has the following groups:- Group 1: TruGraf - Group 1:
- Group 2: CPMC Standard of Care - Group 2:
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current enrollment for this research project?
"Affirmative. According to the data hosted on clinicaltrials.gov, this research initiative - which was initially posted on June 3rd 2021 - is currently recruiting patients. 75 volunteers are needed at one single site for completion of the trial."
Answered by AI
Are there any vacancies in the trial that can be filled by participants?
"Affirmative. The information hosted on clinicaltrials.gov indicates that this study is actively recruiting individuals - the first post was published June 3rd 2021 and the most recent update occurred August 26th of this year. Currently, 75 volunteers need to be sourced from a single medical site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger